Gene · 7225
Papers2,972
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 2,972
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Structural and accessibility studies highlight the differential binding of clemizole to TRPC5 and TRPC6. | J Biomol Struct Dyn | 2025 | 38279926 | PubTator, text mining | PubMed |
| TRPC6 is a Biomarker for Prognosis and Immunotherapy of Stomach Adenocarcinoma Based on Bioinformatic Analysis and Experimental Validation. | Immunotargets Ther | 2024 | 39691169 | PubTator, text mining | PubMed |
| The cation channel mechanisms of subthreshold inward depolarizing currents in the mice VTA dopaminergic neurons and their roles in the chronic-stress-induced depression-like behavior. | Elife | 2024 | 39642080 | PubTator, text mining | PubMed |
| TRPC6 is a mechanosensitive channel essential for ultrasound neuromodulation in the mammalian brain. | Proc Natl Acad Sci U S A | 2024 | 39625977 | PubTator, text mining | PubMed |
| Focus on podocytes: diabetic kidney disease and renal fibrosis - a global bibliometric analysis (2000-2024). | Front Pharmacol | 2024 | 39619610 | PubTator, text mining | PubMed |
| Identification of a factor that accelerates substrate release from the signal recognition particle. | Science | 2024 | 39607913 | PubTator, text mining | PubMed |
| TRPC6 knockdown-mediated ERK1/2 inactivation alleviates podocyte injury in minimal change disease via upregulating Lon peptidase 1. | Ren Fail | 2024 | 39566913 | PubTator, text mining | PubMed |
| Anti-Tumor Necrosis Factor Treatment for Glomerulopathy: Case Report and Review of Literature. | Fed Pract | 2024 | 39410922 | PubTator, text mining | PubMed |
| Photoswitchable TRPC6 channel activators evoke distinct channel kinetics reflecting different gating behaviors. | iScience | 2024 | 39403196 | PubTator, text mining | PubMed |
| Echinacoside inhibits PASMCs calcium overload to prevent hypoxic pulmonary artery remodeling by regulating TRPC1/4/6 and calmodulin. | Open Med (Wars) | 2024 | 39381430 | PubTator, text mining | PubMed |
| TRPC3/6 Channels Mediate Mechanical Pain Hypersensitivity via Enhancement of Nociceptor Excitability and of Spinal Synaptic Transmission. | Adv Sci (Weinh) | 2024 | 39340833 | PubTator, text mining | PubMed |
| Effects of zinc in podocytes and cortical collecting duct in vitro and Dahl salt-sensitive rats in vivo. | J Biol Chem | 2024 | 39276935 | PubTator, text mining | PubMed |
| Transient receptor potential channels as an emerging target for the treatment of Alzheimer's disease: Unravelling the potential of pharmacological interventions. | Basic Clin Pharmacol Toxicol | 2024 | 39209323 | PubTator, text mining | PubMed |
| TRPC6 is ubiquitously present in lymphatic tissues: A study using samples from body donors. | Med Int (Lond) | 2024 | 39161881 | PubTator, text mining | PubMed |
Delivery of siRNAs Against Selective Ion Channels and Transporter Genes Using Hyaluronic Acid-coupled Carbonate Apatite Nanoparticles Synergistically Inhibits Growth and Survival of Breast Cancer Cells. | Int J Nanomedicine | 2024 | 39099788 | PubTator, text mining | PubMed |
| Immunohistochemical expression of the cation channel TRPC6 in the submandibular and lacrimal gland and in salivary gland tumors. | Pathol Res Pract | 2024 | 39098247 | PubTator, text mining | PubMed |
| The roles of TRPC6 in renal tubular disorders: a narrative review. | Ren Fail | 2024 | 39022902 | PubTator, text mining | PubMed |
| Role of TRPC6 in apoptosis of skeletal muscle ischemia/reperfusion injury. | Cell Signal | 2024 | 38971570 | PubTator, text mining | PubMed |
| Effect of electroacupuncture on myocardial transient receptor potential channels in mice with myocardial hypertrophy. | Zhen Ci Yan Jiu | 2024 | 38897799 | PubTator, text mining | PubMed |
| Distribution of TRPC3 and TRPC6 in the human exocrine and endocrine pancreas. | Pathol Res Pract | 2024 | 38870712 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7225/papers?page=7